Navigation Links
FASEB SRC announces conference: TGF-β Superfamily: Signaling in Development & Disease
Date:2/4/2013

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): TGF-β Superfamily: Signaling in Development and Disease.

The 2013 "TGF-β Superfamily: Signaling in Development and Disease" is an important and unique scientific conference where the pivotal role of TGF- family members in developmental and homeostatic processes is explored through formal talks, poster sessions, and interactive and intensive scientific discussion sessions. The sessions are organized in different themes and are all held in an intimate setting with a limited number of participants.

This meeting includes outstanding researchers from around the world presenting diverse, cutting edge and forward looking research directed towards a fundamental understanding of the mechanisms of TGF-β family signaling: how these factors coordinate developmental processes, how aberrations in this signaling pathway lead to developmental abnormalities and human disease pathologies, and how this knowledge may come to be applied in the clinic.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB SRC announces conference registration open for: Mobile DNA in Mammalian Genomes
2. FASEB SRC announces conference registration open for: NAD Metabolism & Signaling
3. FASEB SRC announces conference registration open for: Histone Deacetylases, Sirtuins, and Reversible Acetylation in Signaling and Disease
4. FASEB SRC announces conference registration open for: Genetic Recombination & Genome Rearrangements
5. FASEB SRC announces conference registration open for: Signal Transduction in the Immune System
6. FASEB SRC announces conference registration open for: Biology of Cilia and Flagella
7. FASEB SRC announces conference registration open for: Arf and Rab Family G Proteins
8. FASEB SRC announces conference: Glucose transport -- Gateway for Metabolic Systems Biology
9. FASEB SRC announces conference: Mitochondrial Assembly & Dynamics in Health, Disease & Aging
10. FASEB SRC announces: Molecular Mechanisms & Physiological Consequences of Protein Aggregation
11. FASEB SRC announces conference registration open for: Neural Mechanisms in Cardiovascular Regulation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... , ... February 10, 2016 , ... ... the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st Annual Vendor ... expecting to fill more than 100 tables for its annual event, which will ...
(Date:2/10/2016)... ... February 10, 2016 , ... PatientCrossroads announces ... the secure online PatientCrossroads platform, has exceeded both its one-year and overall recruitment ... PROMPT study, which seeks to advance understanding of the hereditary risks for certain ...
(Date:2/10/2016)... ... February 10, 2016 , ... Cenna Bioscience Inc., an ... treatment of Alzheimer’s disease, announced today it has been selected to present at the ... Breakers in Palm Beach, Florida. The purpose of the Forum is to help ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
Breaking Biology Technology: